OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant

22 أكتوبر 2023 01:55:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

17 أكتوبر 2023 06:01:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress

16 أكتوبر 2023 06:02:00 بحسب Nasdaq GlobeNewswire

Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity

12 أكتوبر 2023 06:01:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Expansion of Collaboration Agreement with Novartis

10 أكتوبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 أكتوبر 2023 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

20 سبتمبر 2023 06:29:20 بحسب Nasdaq GlobeNewswire

Olema Oncology to Participate in Upcoming Investor Conferences

06 سبتمبر 2023 15:30:55 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 سبتمبر 2023 15:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Combined Financing for Up to $180 Million

05 سبتمبر 2023 06:30:49 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 أغسطس 2023 15:03:07 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 أغسطس 2023 15:30:34 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference

01 أغسطس 2023 07:00:10 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 يوليو 2023 06:30:32 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 يونيو 2023 15:30:23 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

30 مايو 2023 15:30:43 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

11 مايو 2023 07:43:20 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 مايو 2023 15:01:03 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

08 مايو 2023 06:06:10 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مايو 2023 15:30:57 بحسب Nasdaq GlobeNewswire